64Cu/*Pd-GluCAB: an in vivo albumin-binding theranostic radiopharmaceutical for dual active and passive targeting of breast cancer - Archive ouverte HAL Accéder directement au contenu
Poster De Conférence Année : 2023

64Cu/*Pd-GluCAB: an in vivo albumin-binding theranostic radiopharmaceutical for dual active and passive targeting of breast cancer

Domaines

Chimie
Fichier non déposé

Dates et versions

hal-04547303 , version 1 (15-04-2024)

Identifiants

  • HAL Id : hal-04547303 , version 1

Citer

Nathalie Le Bris, Raphaël Tripier. 64Cu/*Pd-GluCAB: an in vivo albumin-binding theranostic radiopharmaceutical for dual active and passive targeting of breast cancer. International Symposium on Trends in Radiopharmaceuticals, Apr 2023, Vienna, Austria. ⟨hal-04547303⟩
0 Consultations
0 Téléchargements

Partager

Gmail Facebook X LinkedIn More